T-VEC Injections Safe in patients with Advanced-Stage Liver Metastases

According to early results of an ongoing early-phase trial presented at the 2018 Society of Interventional Radiology Annual Scientific Meeting, image-guided injections of talimogene laherparepvec immunotherapy (T-VEC, Imylgic) were deemed tolerable in patients with advanced-stage liver metastases.

Read full article (External website)

1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply